Target intelligence / Profile preview

Mitochondrial electron transport chain complex I, II, III, IV, and V proteins (ETC complexes I-V (or Complex I, II, III, IV, V))

Target
ETC complexes I-V (or Complex I, II, III, IV, V)
Molecular classification
Enzyme, Oxidoreductase (Complex I, II, III, IV), ATP synthase (Complex V), Transmembrane protein complex
01

Overview

The mitochondrial electron transport chain comprises five major protein complexes (I-V), embedded in the inner membrane, that work together to oxidize electron donors (NADH, FADH2), transport electrons through a series of redox reactions, pump protons to create an electrochemical gradient, and synthesize ATP from ADP and inorganic phosphate via ATP synthase (complex V). Complexes I-IV transfer electrons and pump protons, while complex V uses the proton gradient to drive ATP synthesis. Dysfunction or inhibition of these complexes can result in severe metabolic and degenerative diseases, and they are targets for several drugs and toxins.

Other names
Complex I: NADH:ubiquinone oxidoreductaseNADH dehydrogenaseComplex II: Succinate dehydrogenasesuccinate:ubiquinone oxidoreductaseComplex III: Cytochrome bc1 complexubiquinol:cytochrome c oxidoreductaseComplex IV: Cytochrome c oxidaseComplex V: ATP synthaseF1F0-ATP synthaseOxidative phosphorylation complexesmitochondrial respiratory complexesETC proteins
02

Mechanism of action

Inhibition of electron transfer Disruption of proton gradient (uncoupling) Inhibition of ATP synthesis Generation of reactive oxygen species (ROS)

03

Biological functions

Cellular energy production (ATP synthesis)Oxidative phosphorylationProton gradient generationElectron transportApoptosis regulation
04

Disease associations

Neurodegenerative disease (e.g., Parkinson’s, Alzheimer’s)Cardiovascular diseaseMitochondrial disorders (e.g., Leigh syndrome, MELAS)CancerMetabolic syndromesAging
05

Safety considerations

Systemic toxicity from ETC inhibition (e.g., lactic acidosis)Cellular energy crisis and multi-organ failureOxidative stress, tissue damage from ROSMitochondrial dysfunction leading to apoptosis or necrosis
06

Interacting drugs

Rotenone (Complex I inhibitor)

8 more in the full profile.

07

Biomarkers

Reduced/oxidized NADH/NAD+ ratioATP/ADP ratioLactate/pyruvate ratio (for dysfunctional ETC)Mitochondrial DNA deletions or mutations (for genetic diseases)Activity assays of individual complexes (biochemical diagnosis)

Beyond the preview

Go deeper on Mitochondrial electron transport chain complex I, II, III, IV, and V proteins (ETC complexes I-V (or Complex I, II, III, IV, V)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial electron transport chain complex I, II, III, IV, and V proteins (ETC complexes I-V (or Complex I, II, III, IV, V)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call